<VariationArchive RecordType="classified" VariationID="5886" VariationName="POLH, 2-BP DEL, NT770" VariationType="Deletion" Accession="VCV000005886" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-09-10" DateCreated="2016-10-02" MostRecentSubmission="2016-10-02">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="20925" VariationID="5886">
      <GeneList>
        <Gene Symbol="POLH" FullName="DNA polymerase eta" GeneID="5429" HGNC_ID="HGNC:9181" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>6p21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="43576185" stop="43620523" display_start="43576185" display_stop="43620523" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="43543877" stop="43588259" display_start="43543877" display_stop="43588259" Strand="+" />
          </Location>
          <OMIM>603968</OMIM>
        </Gene>
      </GeneList>
      <Name>POLH, 2-BP DEL, NT770</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6p21.1-p12</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>2-BP DEL, NT770</Name>
      </OtherNameList>
      <XRefList>
        <XRef Type="Allelic variant" ID="603968.0003" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="POLH, 2-BP DEL, NT770 AND Xeroderma pigmentosum variant type" Accession="RCV000006244" Version="3">
        <ClassifiedConditionList TraitSetID="1635">
          <ClassifiedCondition DB="MedGen" ID="C1848410">Xeroderma pigmentosum variant type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1999-06-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1999-06-17" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-10-02" MostRecentSubmission="2016-10-02">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10385124</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1635" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5132" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Xeroderma pigmentosum with normal DNA repair rates</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Photosensitivity with defective DNA synthesis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Xeroderma pigmentosum variant type</ElementValue>
                <XRef ID="MONDO:0010214" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">XPV</ElementValue>
                <XRef Type="MIM" ID="278750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).</Attribute>
                <XRef ID="NBK1397" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5630" />
                <XRef ID="5630" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301571</ID>
                <ID Source="BookShelf">NBK1397</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="90342" DB="Orphanet" />
              <XRef ID="C1848410" DB="MedGen" />
              <XRef ID="MONDO:0010214" DB="MONDO" />
              <XRef Type="MIM" ID="278750" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="26426" SubmissionDate="2016-09-28" DateLastUpdated="2016-10-02" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603968.0003_XERODERMA PIGMENTOSUM, VARIANT TYPE" title="POLH, 2-BP DEL, NT770_XERODERMA PIGMENTOSUM, VARIANT TYPE" />
        <ClinVarAccession Accession="SCV000026426" DateUpdated="2016-10-02" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1999-06-17">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In the XPV (278750) cell line XP7TA, Masutani et al. (1999) identified deletion of 2 nucleotides at position 770-771.</Attribute>
              <Citation>
                <ID Source="PubMed">10385124</ID>
              </Citation>
              <XRef DB="OMIM" ID="278750" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POLH" />
          </GeneList>
          <Name>POLH, 2-BP DEL, NT770</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, NT770</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603968.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">XERODERMA PIGMENTOSUM, VARIANT TYPE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="26426" TraitType="Disease" MappingType="Name" MappingValue="XERODERMA PIGMENTOSUM, VARIANT TYPE" MappingRef="Preferred">
        <MedGen CUI="C1848410" Name="Xeroderma pigmentosum variant type" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

